CIII allows people who have tried at least two oral antidepressants to use the spray on its own – without the need for more ...

Ketamine therapy has become known for its effects at combating depression and other mood disorders. There’s a growing body of ...

Fact checked by Nick Blackmer The Food and Drug Administration (FDA) has expanded its approval of a ketamine nasal spray, ...

Effective treatments for people with serious depression who have not been helped by antidepressant medications have novel ...

Scientists at Virginia Tech are revolutionizing depression treatment by tapping into how the brain processes rewards. Their ...

Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the ...

The U.S. Food and Drug Administration expanded approval for Johnson & Johnson’s nasal spray, Spravato, to allow it to be used ...

Share on Pinterest The FDA has approved an esketamine nasal spray for the treatment of depression cases that do not respond to other therapeutic approaches. Image credit: Koldunov/Getty Images.

More and more young people are struggling with their mental health, especially boys and young men who may not open up about their struggles as easily as girls.

Men experience and express depression differently, often coping through unhealthy behaviors and resisting treatment due to ...

The U.S. Food and Drug Administration ( FDA) has approved the use of a nasal spray as a standalone treatment for major depressive disorder, offering a new option for those struggling with ...

The approval of Spravato for the monotherapy indication in TRD was supported by data from the randomized, double-blind, ...